Vizimaco

Medicinal product

(Invented) name

Vizimaco

Active substance (s)

Bimatoprostas/Timololis

Strength

0,3 mg/5 mg/ml

Pharmaceutical form

akių lašai (tirpalas)

Route (s) of administration

vartoti ant akių

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

S01ED51, Timolol, combinations

Marketing authorisation holder

BAUSCH + LOMB IRELAND LIMITED, Airija

Date of authorisation

2017-12-12

Date of renewal

Documents

4169 Vizimaco PCS PL 2022 12 02.docx

4169 Pakuotės lapelis 2022 12 02.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(3)

Procedure number

DK/H/2711/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

1 ml tirpalo yra	1 ml
Bimatoprostas	0,3 mg
Timololis	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
98528	84631	1084631	buteliukas	3 ml N1		Receptinis	LT/1/17/4169/001	Netiekiama	-	-	No	-	-
98529	84632	1084632	buteliukas	3 ml N3		Receptinis	LT/1/17/4169/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-04-30	Išregistruotas
2017-12-12	Registruotas